February 19, 1996.
On this day, Campuscape, the IUPUI campuswide monthly newsletter, reported that the Indiana University Board of Trustees had approved the construction of a two-story clinical research facility on top of the four-story University Hospital Outpatient Center. The facility would be used by pharmaceutical firm Eli Lilly and Company. The Lilly Laboratory for Clinical Research, projected to cost $17 million, would afford space for volunteers to take part in drug studies.
Dr. August M. Watanabe, vice president of Lilly and president of Lilly Research Laboratories (and formerly chair of the Department of Medicine in the IU School of Medicine), noted that the company had locations worldwide but concluded to "maintain our investment in Indianapolis." School of Medicine dean Robert W. Holden opined that the facility "will have a positive impact on our community and on this medical center."
To learn more about cooperation between the IU School of Medicine and Eli Lilly and Company, please consult records in the IUPUI Special Collections and Archives. Contact us at firstname.lastname@example.org.